29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

"Nucleic Acid Drug Delivery: Triumphs and Challenges" explores the potential of RNA interference (RNAi) as a targeted cancer therapy, offering a more precise and effective alternative to conventional chemotherapy. The book discusses how RNAi, through small interfering RNA (siRNA) and microRNA (miRNA), can selectively silence oncogenes, thereby reducing the off-target effects and toxicity associated with traditional treatments. It also addresses the challenges of RNA delivery, focusing on advancements like lipid nanoparticles (LNPs) and other novel systems designed to enhance stability,…mehr

Produktbeschreibung
"Nucleic Acid Drug Delivery: Triumphs and Challenges" explores the potential of RNA interference (RNAi) as a targeted cancer therapy, offering a more precise and effective alternative to conventional chemotherapy. The book discusses how RNAi, through small interfering RNA (siRNA) and microRNA (miRNA), can selectively silence oncogenes, thereby reducing the off-target effects and toxicity associated with traditional treatments. It also addresses the challenges of RNA delivery, focusing on advancements like lipid nanoparticles (LNPs) and other novel systems designed to enhance stability, bioavailability, and targeting efficiency. Additionally, the book highlights the clinical success of Patisiran, an FDA-approved RNAi-based drug, as a milestone in RNAi therapy, paving the way for broader applications in cancer treatment. With ongoing research and innovation, RNAi-based therapies offer a promising future in oncology, providing safer, more effective treatment options that could revolutionize cancer care. The book delves into these advancements while exploring the obstacles and the vast potential of nucleic acid-based drug delivery systems for improved therapeutic outcomes.
Autorenporträt
Il Dr. Sharma è un esperto di formulazioni farmaceutiche e sistemi di rilascio dei farmaci, con oltre un decennio di esperienza di ricerca. È autore di numerose pubblicazioni di grande impatto sulle tecnologie innovative di somministrazione dei farmaci, che hanno permesso di migliorare la precisione e la sicurezza delle terapie farmaceutiche, in particolare in oncologia.